Abstract
The effect of short-term oral zinc supplementation (zinc sulfate 600 mg/day) on hepatic encephalopathy, was assessed in a double-blind, crossover trial. Fifteen cirrhotic patients with stable, chronic hepatic encephalopathy were randomized to receive either oral zinc or a placebo for 10 days. Following a two-week washout period, these were crossed over to the alternate treatment. Conn's index, which comprises the evaluation of the mental state, asterixis, number connection test, EEG record, and plasma ammonia, was used to score the degree of hepatic encephalopathy, both at the beginning and end of each treatment period. Serum zinc was significantly raised after oral zinc administration and reached the levels observed in cirrhotics without hepatic encephalopathy. Despite this, however, no modification in the parameters included in Conn's index were observed. In conclusion, this study failed to confirm that short-term oral zinc supplementation improves chronic hepatic encephalopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vallee BL, Wacker WEC, Bartholomay AF, Robin ED: Zinc metabolism in hepatic dysfunction. N Engl J Med 225:403–408, 1956
Scholmerich J, Lohla E, Gerok W: Zinc and vitamin A deficiency in liver cirrhosis. Hepato-Gastroenterol 30:119–125, 1983
Valberg LS, Flanagan PR, Ghent CN: Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis. Dig Dis Sci 30:329–333, 1985
Scholmerich J, Becher MS, Kottgen E, Rauch N, Haussinger D, Lohle E, Vuilleumier JP, Gerok W: The influence of portosystemic shunting on zinc and vitamin A metabolism in liver cirrhosis. Hepato-Gastroenterol 30:143–147, 1983
Rabbani P, Prasad AS: Plasma ammonia and liver ornithine transcarbamylase activity in zinc-deficient rats. Am J Physiol 235:E203-E206, 1978
Cassidy WA, Broen ED, Smith CJ: Alterations in zinc and vitamin A metabolism in alcoholic liver disease: A review.In Zinc and Copper in Clinical Medicine. KM Hambridge, BL Nichols (eds). New York, SP Medical and Scientific Books, 1978, pp 59–79
Riggio O, Merli M, Ariosto F, Pieche U, Capocaccia L: Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase (OCT) activity in experimental cirrhosis. Hepatology 12:858, 1990 (abstract)
Baraldi M, Caselgrandi E, Borella P, Zeneroli L: Decrease of brain zinc in experimental hepatic encephalopathy. Brain Res 258:170–172, 1982
Walwork JC, Botnen JH, Sanstead LL: Influence of dietary zinc on rat brain catecolamines. J Nutr 112:514–519, 1982
Reding P, Duchateau J, Bataille C: Oral zinc supplementation improves hepatic encephalopathy. Lancet 1:493–495, 1984
Maier KP: Progress in the treatment of portal-systemic encephalopathy (PSE). J Hepatol 5:355–361, 1987
Uribe M: Dietary management of portal systemic encephalopathy.In Hepatic Encephalopathy: Management with Lactulose and Related Carbohydrates. HO Conn, J Bircher (eds). Michigan, Medi-Ed Press, 1988, pp
Conn HO, Leevy CM, Vlavechic ZR, Rodgers DB, Maddrey NC, Seeff L, Levy LL: A comparison of lactulose and neomycin in the treatment of portal-systemic encephalopathy: A double blind controlled trial. Gastroenterol 72:573–583, 1977
Morgan MY, Hewley KE, Stambuk D: Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. J Hepatol 4:236–244, 1987
Uribe M, Toledo H, Perez F, Vargas F, Gil S, Garcia-Ramos G, et al: Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. Dig Dis Sci 32:1345–1353, 1987
Swart GR, Van den Berg JWO, Wattimena JLD, Rietveld T, Van Vuure JK, Frenkel M: Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies. Clin Sci 75:101–107, 1988
Swart GR, Van den Berg JWO, Van Vuure JK, Rietveld T, Wattimena DL, Frenkel M: Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intake. Clin Nutr 8:329–336, 1989
Karayalcin S, Arcasoy A, Uzunalimoglu O: Zinc plasma levels after oral inc tolerance test in nonalcoholic cirrhosis. Dig Dis Sci 33:1096–1102, 1988
Boyett JD, Sullivan JF: Distribution of protein-bound zinc in normal and cirrhotic serum. Metabolism 19:148–151, 1970
Solomon MV, Cousins RJ: Zinc.In Absorption and Malabsorption of Mineral Nutrients. NW Solomon, IH Rosemberg (eds). New York, Alan R Liss, 1984, pp 122–138
Scholmerich J, Freudemann A, Kottgen E, Wietholtz H, Steiert B, Lohle E, Haussinger D, Gerok W: Bioavailability of zinc from zinc-histidine complexes. I Comparison with zinc sulfate in healthy men. Am J Clin Nutr 45:1486–1489, 1987
Scholmerich J, Krauss E, Wietholtz H, Kottgen E, Lohle E, Gerok W: Bioavailability of zinc from zinc-histidine complexes. II Studies on patients with liver cirrhosis and the influence of the time application. Am J Clin Nutr 45:1487–1491, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Riggio, O., Ariosto, F., Merli, M. et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Digest Dis Sci 36, 1204–1208 (1991). https://doi.org/10.1007/BF01307509
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01307509